Article metrics

Download PDFPDF
Potential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma

 

Online download statistics by month:

Online download statistics by month: March 2019 to May 2024

AbstractFullPdf
Mar 20191201
Apr 20192900
May 20193100
Jun 20191800
Jul 20192300
Aug 20192000
Sep 20191700
Oct 20191400
Nov 2019600
Dec 20192601
Jan 20201900
Feb 20201800
Mar 2020500
Apr 20201000
May 20201400
Jun 20202000
Jul 20201200
Aug 2020600
Sep 2020800
Oct 20201000
Nov 2020500
Dec 2020800
Jan 20211001
Feb 2021600
Mar 20212201
Apr 20211000
May 2021200
Oct 20212404
Nov 2021800
Dec 20212200
Jan 20221500
Feb 2022700
Mar 20221400
Apr 20222100
May 20224500
Jun 20224800
Jul 20221800
Aug 20224000
Sep 20223400
Oct 20222800
Nov 20222400
Dec 20221800
Jan 20232200
Feb 20237200
Mar 20231700
Apr 2023400
May 2023500
Jun 2023800
Jul 2023700
Aug 20231200
Sep 20231200
Oct 20231101
Nov 20231702
Dec 20232001
Jan 2024600
Feb 20241000
Mar 20242601
Apr 20242700
May 20242801
Total1051014